Viking Therapeutics ( VKTX -0.30%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...
I've played a few Skyrim mods that stank in my time, but none quite like this. Everyone Poops—Mihail's Shards of Immersion ...
The Minnesota Vikings appear to be out on Aaron Rodgers, but they haven't completely closed the door on the future Hall of ...
With vice president of sales and national accounts Michele Saegesser departing Viking, the company has promoted Erik De La ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
The routes for this Saturday’s Viking Half Marathon, 10K and 5K  have been revamped to bring variety and an improved experience for participants. All races for the 14th annual event will begin and ...
Viking Holdings shares dropped Tuesday as executives warned of macroeconomic "uncertainties" on the cruise operator's ...
Consumers across Europe furious over President Donald Trump’s policies are boycotting U.S. goods. Among the most passionate ...
Viking has launched its 2025 European river season, with its fleet of Viking Longships setting sail along Europe’s waterways, ...
Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results